Nifty

:

18114.90

Sensex

:

60821.62

-63.20 (-0.35%)
-101.88 (-0.17%)

Login

Nifty
Sensex

:
:

18114.90
60821.62

-63.20 (-0.35%)
-101.88 (-0.17%)

Sequent Scientific Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

42/99

BSE: 512529 | NSE: SEQUENT

Watchlist

NSE BSE

195.20

21-Oct-2021

Open
High
Low
Previous Close

206.70
208.75
192.45
205.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1486721
2940.95
336.50
136.85

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,856.89
61.01
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,024.49
0.26%
6.75

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.69
14.78
9.42

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.05
39.23
11.16

PAT CAGR (%)

10 Years
5 Years
3 Years

36.12
-
25.18

P:E (Median)

8 Years
5 Years
3 Years

-
30.58
34.30

P:BV (Average)

8 Years
5 Years
3 Years

7.85
3.79
4.53

EV:EBITDA (Average)

8 Years
5 Years
3 Years

60.02
23.17
19.49

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 46.66 55.35 -15.70% 69.48 62.29 11.54% 70.57 61.80 14.19% 69.64 51.52 35.17%
Expenses 50.82 46.68 8.87% 66.60 51.76 28.67% 57.34 55.94 2.50% 59.17 48.72 21.45%
EBITDA -4.16 8.66 - 2.88 10.54 -72.68% 13.24 5.86 125.94% 10.47 2.80 273.93%
EBIDTM -8.92% 15.66% 4.14% 16.92% 18.76% 9.49% 15.03% 5.43%
Other Income 5.76 2.27 153.74% 5.92 3.05 94.10% 5.67 2.22 155.41% 6.10 7.26 -15.98%
Interest 0.17 1.10 -84.55% 0.25 1.23 -79.67% 0.60 1.19 -49.58% 0.73 1.19 -38.66%
Depreciation 2.31 2.16 6.94% 2.61 2.31 12.99% 2.19 2.19 0.00% 2.16 2.23 -3.14%
PBT -0.87 7.67 - 6.03 10.06 -40.06% 16.11 4.69 243.50% 11.03 6.64 66.11%
Tax -0.26 1.65 - 1.39 3.24 -57.10% 3.94 1.77 122.60% 1.82 -3.54 -
PAT -0.61 6.03 - 4.64 6.82 -31.96% 12.17 2.92 316.78% 9.21 10.18 -9.53%
PATM -1.31% 10.89% 6.68% 10.94% 17.24% 4.72% 13.23% 19.77%
EPS -0.02 0.24 - 0.19 0.27 -29.63% 0.49 0.12 308.33% 0.37 0.41 -9.76%

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 320.51 295.26 8.55% 361.82 300.58 20.37% 358.21 316.42 13.21% 346.27 284.22 21.83%
Expenses 300.35 249.78 20.25% 318.54 255.85 24.50% 291.91 266.44 9.56% 289.88 247.06 17.33%
EBITDA 20.16 45.48 -55.67% 43.28 44.74 -3.26% 66.31 49.98 32.67% 56.39 37.16 51.75%
EBIDTM 6.29% 15.40% 11.96% 14.88% 18.51% 15.80% 16.29% 13.07%
Other Income 2.67 1.55 72.26% 1.37 1.83 -25.14% 2.81 0.98 186.73% 2.64 5.97 -55.78%
Interest 3.02 7.65 -60.52% 3.18 9.33 -65.92% 6.20 9.60 -35.42% 7.36 7.84 -6.12%
Depreciation 12.57 13.03 -3.53% 12.68 13.09 -3.13% 11.58 13.05 -11.26% 13.30 12.46 6.74%
PBT 7.23 26.35 -72.56% 29.01 24.14 20.17% 51.33 28.31 81.31% 29.32 22.83 28.43%
Tax 4.58 7.00 -34.57% 5.49 5.91 -7.11% 11.64 4.25 173.88% 7.96 -1.64 -
PAT 2.65 19.35 -86.30% 23.52 18.23 29.02% 39.69 24.06 64.96% 21.36 24.47 -12.71%
PATM 0.83% 6.55% 6.50% 6.06% 11.08% 7.60% 6.17% 8.61%
EPS 0.04 0.64 -93.75% 0.83 0.68 22.06% 1.50 0.82 82.93% 0.86 0.86 0.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 256.35 265.46 227.33 166.26 271.20 105.87 394.59 444.82 445.08 235.77 332.43 Net Sales Growth 10.99% 16.77% 36.73% -38.69% 156.16% -73.17% -11.29% -0.06% 88.78% -29.08% Cost Of Goods Sold 99.96 108.87 113.04 94.62 161.37 72.47 218.33 229.86 245.55 133.20 190.11 Gross Profit 156.39 156.59 114.29 71.64 109.83 33.40 176.26 214.95 199.53 102.57 142.32 GP Margin 61.01% 58.99% 50.27% 43.09% 40.50% 31.55% 44.67% 48.32% 44.83% 43.50% 42.81% Total Expenditure 233.93 230.17 205.10 163.57 258.06 121.27 359.06 384.54 437.81 253.85 296.96 Power & Fuel Cost - 12.77 12.73 8.52 2.32 2.14 17.98 20.68 21.77 17.98 20.21 % Of Sales - 4.81% 5.60% 5.12% 0.86% 2.02% 4.56% 4.65% 4.89% 7.63% 6.08% Employee Cost - 22.42 17.10 10.71 25.12 17.90 38.84 45.47 42.87 29.10 25.44 % Of Sales - 8.45% 7.52% 6.44% 9.26% 16.91% 9.84% 10.22% 9.63% 12.34% 7.65% Manufacturing Exp. - 60.33 51.52 41.13 15.87 14.85 56.50 48.54 49.63 34.33 26.30 % Of Sales - 22.73% 22.66% 24.74% 5.85% 14.03% 14.32% 10.91% 11.15% 14.56% 7.91% General & Admin Exp. - 15.28 6.90 7.15 13.02 9.92 15.19 23.99 41.71 14.93 10.56 % Of Sales - 5.76% 3.04% 4.30% 4.80% 9.37% 3.85% 5.39% 9.37% 6.33% 3.18% Selling & Distn. Exp. - 4.02 2.11 1.04 0.83 0.47 4.03 5.71 7.90 7.03 9.12 % Of Sales - 1.51% 0.93% 0.63% 0.31% 0.44% 1.02% 1.28% 1.77% 2.98% 2.74% Miscellaneous Exp. - 6.48 1.68 0.40 39.53 3.53 8.19 10.29 28.37 17.28 9.12 % Of Sales - 2.44% 0.74% 0.24% 14.58% 3.33% 2.08% 2.31% 6.37% 7.33% 4.58% EBITDA 22.43 35.29 22.23 2.69 13.14 -15.40 35.53 60.28 7.27 -18.08 35.47 EBITDA Margin 8.75% 13.29% 9.78% 1.62% 4.85% -14.55% 9.00% 13.55% 1.63% -7.67% 10.67% Other Income 23.45 19.97 14.56 13.96 24.67 19.07 15.55 3.56 5.25 2.92 11.33 Interest 1.75 2.68 5.04 3.22 4.54 0.42 16.44 47.46 38.74 24.64 28.27 Depreciation 9.27 9.13 8.95 7.22 14.37 3.25 24.18 26.38 27.13 23.00 21.03 PBT 32.30 43.45 22.81 6.20 18.90 -0.01 10.46 -9.99 -53.34 -62.81 -2.50 Tax 6.89 8.77 1.47 -1.38 2.87 0.00 0.07 1.70 0.00 -8.31 -3.96 Tax Rate 21.33% 21.45% 6.44% -22.26% 0.70% 0.00% 0.67% 3.95% 0.00% 13.23% 158.40% PAT 25.41 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 -54.50 1.47 PAT before Minority Interest 25.41 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 -54.50 1.47 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.91% 12.10% 9.39% 4.57% 149.86% -0.01% 2.63% 9.29% -25.71% -23.12% 0.44% PAT Growth -2.08% 50.47% 181.16% -98.13% - - -74.85% - - - EPS 1.02 1.29 0.86 0.31 16.36 0.00 0.42 1.66 -4.61 -2.19 0.06

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 1,386.81 1,361.62 1,179.24 1,039.31 1,030.59 683.57 624.98 465.36 455.46 326.86 345.81 Net Sales Growth 15.91% 15.47% 13.46% 0.85% 50.77% 9.37% 34.30% 2.17% 39.34% -5.48% Cost Of Goods Sold 711.14 694.65 605.05 543.01 554.23 356.70 311.71 240.72 243.65 181.72 192.27 Gross Profit 675.67 666.96 574.19 496.30 476.36 326.87 313.27 224.65 211.81 145.14 153.53 GP Margin 48.72% 48.98% 48.69% 47.75% 46.22% 47.82% 50.12% 48.27% 46.50% 44.40% 44.40% Total Expenditure 1,200.68 1,149.55 1,008.92 914.37 919.10 643.03 568.27 444.87 438.68 342.51 308.74 Power & Fuel Cost - 28.75 24.73 23.06 14.66 12.77 26.51 23.32 22.06 23.53 20.21 % Of Sales - 2.11% 2.10% 2.22% 1.42% 1.87% 4.24% 5.01% 4.84% 7.20% 5.84% Employee Cost - 187.22 165.06 145.95 132.07 106.22 88.62 62.39 48.12 41.47 29.40 % Of Sales - 13.75% 14.00% 14.04% 12.81% 15.54% 14.18% 13.41% 10.57% 12.69% 8.50% Manufacturing Exp. - 99.30 83.24 77.73 59.07 57.63 72.14 54.31 52.30 41.42 27.88 % Of Sales - 7.29% 7.06% 7.48% 5.73% 8.43% 11.54% 11.67% 11.48% 12.67% 8.06% General & Admin Exp. - 58.40 56.37 58.35 70.92 48.60 36.44 33.79 43.58 23.96 13.69 % Of Sales - 4.29% 4.78% 5.61% 6.88% 7.11% 5.83% 7.26% 9.57% 7.33% 3.96% Selling & Distn. Exp. - 50.00 45.16 36.29 36.87 28.78 17.46 20.27 12.30 10.51 9.23 % Of Sales - 3.67% 3.83% 3.49% 3.58% 4.21% 2.79% 4.36% 2.70% 3.22% 2.67% Miscellaneous Exp. - 31.21 29.32 29.98 51.29 32.34 15.40 10.07 16.66 19.91 9.23 % Of Sales - 2.29% 2.49% 2.88% 4.98% 4.73% 2.46% 2.16% 3.66% 6.09% 4.64% EBITDA 186.14 212.07 170.32 124.94 111.49 40.54 56.71 20.49 16.78 -15.65 37.07 EBITDA Margin 13.42% 15.57% 14.44% 12.02% 10.82% 5.93% 9.07% 4.40% 3.68% -4.79% 10.72% Other Income 9.49 8.36 10.09 8.67 17.20 11.08 14.30 9.96 3.84 4.96 10.48 Interest 19.76 24.38 35.71 32.80 39.70 28.34 38.56 44.37 39.04 33.45 29.99 Depreciation 50.13 50.60 50.62 41.92 53.30 40.07 46.22 32.94 32.60 28.61 22.98 PBT 116.89 145.45 94.08 58.88 35.70 -16.80 -13.77 -46.85 -51.00 -72.75 -5.41 Tax 29.67 32.18 12.03 2.01 13.46 -0.41 2.62 3.39 0.58 -8.06 -3.95 Tax Rate 25.38% 23.55% 12.79% 3.41% 3.03% 2.44% -19.03% -40.50% -0.53% 11.08% 73.01% PAT 87.22 95.44 69.91 48.66 421.57 -13.83 -18.47 -10.74 -110.49 -64.69 -1.40 PAT before Minority Interest 80.00 104.45 82.05 56.88 430.83 -16.39 -16.39 -11.76 -110.49 -64.69 -1.46 Minority Interest -7.22 -9.01 -12.14 -8.22 -9.26 2.56 -2.08 1.02 0.00 0.00 0.06 PAT Margin 6.29% 7.01% 5.93% 4.68% 40.91% -2.02% -2.96% -2.31% -24.26% -19.79% -0.40% PAT Growth 1.29% 36.52% 43.67% -88.46% - - - - - - EPS 3.51 3.84 2.81 1.96 16.97 -0.56 -0.74 -0.43 -4.45 -2.60 -0.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 1,029.51 886.22 917.79 948.62 1,257.33 1,205.88 156.92 50.25 109.45 126.71 Share Capital 49.67 49.67 49.37 48.75 48.75 47.65 30.48 26.74 23.44 21.34 Total Reserves 972.07 822.45 849.53 882.29 1,193.03 1,134.19 92.50 11.15 74.13 105.37 Non-Current Liabilities 4.80 11.50 36.20 19.01 38.28 42.08 79.95 109.66 113.91 85.77 Secured Loans 0.00 15.16 20.61 0.00 13.98 23.82 56.70 90.47 107.52 61.38 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.35 0.56 0.72 0.88 Long Term Provisions 6.59 4.09 22.30 24.39 28.88 22.84 22.97 18.70 5.68 15.27 Current Liabilities 96.62 105.24 79.87 26.69 168.71 109.89 427.45 414.42 319.83 298.94 Trade Payables 58.75 64.34 52.60 24.56 69.96 73.64 69.81 135.38 145.92 122.57 Other Current Liabilities 2.85 9.30 6.01 1.91 35.29 20.85 86.85 31.38 27.75 71.60 Short Term Borrowings 5.22 14.39 19.27 0.00 63.22 15.04 270.29 241.08 139.47 98.09 Short Term Provisions 29.81 17.22 1.99 0.21 0.24 0.36 0.51 6.58 6.70 6.68 Total Liabilities 1,130.93 1,002.96 1,033.86 994.32 1,464.32 1,357.85 664.32 574.33 543.19 511.42 Net Block 65.78 69.41 52.42 23.68 181.67 169.60 200.88 219.93 205.10 206.29 Gross Block 102.86 99.30 73.33 37.61 230.34 193.00 302.01 338.33 301.32 276.44 Accumulated Depreciation 37.08 29.89 20.90 13.93 48.67 23.40 101.13 118.40 96.22 70.15 Non Current Assets 985.95 879.01 946.46 853.77 1,095.85 1,056.39 421.95 333.95 321.05 293.54 Capital Work in Progress 4.34 3.72 0.03 3.12 32.26 19.97 8.93 11.12 21.51 17.57 Non Current Investment 685.11 738.95 788.16 672.67 834.62 834.87 183.11 65.04 54.57 38.81 Long Term Loans & Adv. 230.43 65.53 83.27 138.79 26.79 23.08 26.30 36.20 38.56 28.57 Other Non Current Assets 0.29 1.39 22.57 15.51 20.52 8.86 2.73 1.66 1.30 2.30 Current Assets 144.99 123.95 87.41 140.54 368.46 301.47 242.38 240.38 222.13 217.89 Current Investments 0.07 18.75 0.10 13.98 62.28 62.29 0.08 0.08 0.18 0.28 Inventories 45.79 31.42 25.33 13.83 62.53 56.19 66.88 101.25 82.67 63.11 Sundry Debtors 61.44 40.79 42.90 78.47 113.03 73.75 98.77 79.66 70.16 82.48 Cash & Bank 0.74 3.72 1.88 3.04 3.06 4.80 27.38 19.13 31.07 15.77 Other Current Assets 36.96 3.61 1.56 1.13 127.56 104.45 49.28 40.26 38.05 56.26 Short Term Loans & Adv. 33.40 25.66 15.65 30.09 114.68 86.38 30.28 36.32 32.06 50.48 Net Current Assets 48.37 18.71 7.54 113.85 199.75 191.58 -185.08 -174.04 -97.69 -81.05 Total Assets 1,130.94 1,002.96 1,033.87 994.31 1,464.31 1,357.86 664.33 574.33 543.18 511.43

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 727.65 687.10 706.69 647.58 976.79 945.71 91.27 56.73 95.00 122.53 Share Capital 49.67 49.67 49.37 48.75 48.75 47.65 30.48 26.74 23.44 21.34 Total Reserves 670.21 623.34 638.43 581.25 912.49 874.01 26.85 -0.37 59.68 101.19 Non-Current Liabilities 152.69 216.46 214.75 227.13 246.20 299.72 277.55 159.23 144.35 104.79 Secured Loans 62.52 108.88 126.94 85.14 141.76 197.50 249.97 150.52 137.32 80.19 Unsecured Loans 31.18 41.18 20.90 18.40 23.38 13.82 0.35 0.56 0.72 0.88 Long Term Provisions 26.30 13.16 30.50 28.54 34.76 28.66 25.70 8.03 6.09 15.49 Current Liabilities 514.00 514.86 440.41 430.93 663.55 290.37 406.09 405.28 345.41 329.56 Trade Payables 229.56 220.38 209.35 160.49 203.04 143.94 90.94 114.59 150.91 123.94 Other Current Liabilities 100.64 104.98 87.80 106.52 259.26 83.23 107.43 56.80 35.63 75.38 Short Term Borrowings 102.91 147.12 127.36 152.41 194.70 56.04 204.31 226.60 151.76 123.34 Short Term Provisions 80.90 42.38 15.90 11.51 6.54 7.17 3.42 7.29 7.12 6.89 Total Liabilities 1,443.00 1,463.16 1,402.10 1,342.62 1,903.76 1,538.02 921.84 625.82 589.34 562.37 Net Block 536.61 576.57 498.14 475.97 684.33 586.48 474.43 237.59 227.26 229.76 Gross Block 754.21 762.46 638.06 581.74 789.60 643.70 596.25 369.07 330.69 305.11 Accumulated Depreciation 217.60 185.89 139.91 105.77 105.27 57.22 121.82 131.48 103.43 75.35 Non Current Assets 676.33 738.86 795.99 804.61 1,176.02 1,047.48 612.00 359.87 358.31 351.94 Capital Work in Progress 29.84 13.42 22.61 18.04 32.55 23.52 39.06 43.04 88.71 64.07 Non Current Investment 76.94 131.29 179.65 221.73 363.97 360.58 58.04 0.04 1.64 0.04 Long Term Loans & Adv. 32.15 14.40 32.27 31.01 37.51 30.35 36.01 76.06 39.28 55.77 Other Non Current Assets 0.79 3.18 63.31 57.86 57.66 46.54 4.47 3.15 1.42 2.30 Current Assets 766.68 724.30 606.12 538.01 727.74 490.54 309.84 265.94 231.04 210.42 Current Investments 5.66 40.18 0.47 17.34 64.12 66.98 0.58 0.08 0.18 0.28 Inventories 264.36 219.42 200.10 158.57 160.81 135.08 94.36 101.40 85.62 68.24 Sundry Debtors 346.14 318.76 278.25 258.35 254.62 192.39 115.44 83.54 65.81 70.41 Cash & Bank 56.20 75.83 72.04 42.45 47.40 25.30 38.46 36.21 33.00 35.88 Other Current Assets 94.34 14.79 8.51 5.25 200.79 70.80 61.01 44.71 46.44 35.62 Short Term Loans & Adv. 77.52 55.33 46.75 56.05 54.48 46.69 41.86 37.47 36.48 28.84 Net Current Assets 252.68 209.44 165.71 107.08 64.19 200.17 -96.25 -139.34 -114.37 -119.13 Total Assets 1,443.01 1,463.16 1,402.11 1,342.62 1,903.76 1,538.02 921.84 625.81 589.35 562.36

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 2.34 30.20 73.80 -4.02 -24.04 100.02 -24.99 -42.37 -12.70 10.40 PBT 43.45 22.81 6.20 409.27 -0.01 10.46 43.01 -114.42 -62.81 -2.50 Adjustment 1.12 1.74 -2.19 -392.74 20.30 33.58 22.54 136.20 61.04 42.30 Changes in Working Capital -25.47 7.84 70.32 -21.10 -42.97 56.92 -89.22 -63.80 -11.41 -26.13 Cash after chg. in Working capital 19.09 32.39 74.34 -4.57 -22.68 100.95 -23.68 -42.01 -13.18 13.68 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -16.76 -2.19 -0.54 0.55 -1.36 -0.93 -1.31 -0.35 0.48 -3.28 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 170.00 -17.68 -114.06 15.60 -46.84 -359.41 23.65 -60.82 -31.29 -41.11 Net Fixed Assets -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 -28.82 -41.67 Net Investments 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 -15.66 -25.20 Others 101.66 -18.58 20.18 -416.52 2.53 256.59 103.21 -23.83 13.19 25.76 Cash from Financing Activity -174.78 -10.71 40.34 -11.78 70.97 247.38 7.96 107.56 38.81 31.58 Net Cash Inflow / Outflow -2.44 1.81 0.07 -0.19 0.09 -12.01 6.62 4.37 -5.17 0.87 Opening Cash & Equivalents 2.87 1.07 1.00 1.19 1.10 13.11 6.48 2.11 7.29 5.78 Closing Cash & Equivalent 0.44 2.87 1.07 1.00 1.19 1.10 13.10 6.48 2.11 7.29

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 114.75 115.33 116.02 45.24 -7.19 -0.05 -23.55 -44.78 -3.82 21.48 PBT 145.45 94.08 58.88 445.79 -16.80 -13.77 -8.37 -109.91 -72.75 -5.41 Adjustment 83.98 91.41 84.47 -313.85 123.31 83.81 35.92 133.52 65.98 46.98 Changes in Working Capital -70.89 -58.30 -27.95 -77.87 -104.37 -71.46 -53.98 -67.45 2.48 -17.29 Cash after chg. in Working capital 158.55 127.18 115.40 54.06 2.14 -1.42 -26.44 -43.84 -4.28 24.27 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -43.79 -11.85 0.62 -8.83 -9.33 1.37 2.89 -0.95 0.46 -2.79 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 9.65 -72.27 -67.69 7.17 -116.18 -315.83 -154.69 -79.95 -54.89 -66.78 Net Fixed Assets -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 -28.82 -41.67 Net Investments 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 -15.66 -25.20 Others -58.69 -73.17 66.55 -424.95 -66.81 300.17 -75.13 -42.96 -10.41 0.09 Cash from Financing Activity -138.75 -42.75 -20.08 -56.96 147.44 308.69 179.41 145.54 34.70 61.94 Net Cash Inflow / Outflow -14.35 0.31 28.25 -4.55 24.07 -7.19 1.17 20.80 -24.02 16.63 Opening Cash & Equivalents 68.10 67.79 39.54 44.10 20.03 21.85 22.96 3.45 27.37 9.17 Closing Cash & Equivalent 53.74 68.10 67.79 39.54 44.10 20.03 21.83 22.96 3.45 27.37

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 41.14 35.11 36.41 38.20 50.95 49.61 8.07 2.83 8.33 11.88 ROA 3.01% 2.10% 0.75% 33.06% 0.00% 1.03% 6.67% -20.48% -10.34% 0.31% ROE 3.39% 2.41% 0.83% 37.41% 0.00% 1.59% 51.35% -168.93% -48.60% 1.16% ROCE 4.45% 2.96% 0.99% 36.09% 0.03% 3.07% 20.15% -19.54% -10.55% 7.93% Fixed Asset Turnover 2.66 2.66 3.00 2.05 0.52 1.65 1.45 1.45 0.85 1.35 Receivable days 69.43 66.55 132.93 127.17 310.76 77.04 70.28 58.94 113.28 71.66 Inventory Days 52.44 45.13 42.89 50.71 197.54 54.96 66.23 72.35 108.19 65.88 Payable days 99.34 103.60 86.82 78.05 239.99 74.47 102.24 128.36 197.86 122.93 Cash Conversion Cycle 22.53 8.08 88.99 99.83 268.31 57.53 34.27 2.92 23.61 14.61 Total Debt/Equity 0.01 0.04 0.05 0.00 0.07 0.04 2.77 9.23 2.72 1.75 Interest Cover 16.26 5.53 2.93 91.09 0.97 1.64 1.91 -1.95 -1.55 0.91

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 28.98 27.10 27.86 25.85 39.44 38.69 3.76 1.97 7.09 11.48 ROA 7.19% 5.73% 4.14% 26.54% -0.95% -1.33% -1.52% -18.19% -11.23% -0.29% ROE 15.00% 12.06% 8.63% 54.15% -1.74% -3.35% -28.10% -201.83% -62.91% -1.19% ROCE 16.25% 12.59% 9.24% 41.28% 0.87% 2.72% 6.93% -16.09% -9.86% 6.98% Fixed Asset Turnover 1.83 1.72 1.74 1.51 0.96 1.03 1.01 1.36 1.08 1.26 Receivable days 87.43 90.45 92.53 90.49 118.40 87.75 74.80 57.30 72.70 64.08 Inventory Days 63.61 63.56 61.85 56.34 78.37 65.41 73.58 71.75 82.12 68.11 Payable days 71.27 80.72 75.36 77.04 104.11 77.28 87.31 115.68 149.32 123.09 Cash Conversion Cycle 79.77 73.29 79.02 69.78 92.66 75.87 61.07 13.36 5.51 9.10 Total Debt/Equity 0.31 0.51 0.47 0.48 0.43 0.34 8.26 15.86 3.74 2.19 Interest Cover 6.60 3.63 2.80 12.19 0.41 0.64 0.81 -1.82 -1.18 0.82

Top Investors:

infinity holdings

unit trust of india investment advisory services limited a/c ascent india fund iii

ashoka india opportunities fund

sbi healthcare opportunities fund

Annual Reports:

News Update:

SeQuent Scientific gets EUGMP approval for tablets dosage manufacturing line in Turkey
15th Jul 2021, 09:23 AM

The company has already embarked upon significant expansion in Turkey to meet the growing requirements of the local market
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback